Morgan Stanley Legend Biotech Corp Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Legend Biotech Corp stock. As of the latest transaction made, Morgan Stanley holds 415,500 shares of LEGN stock, worth $17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

415,500

Previous 375,220 10.74%

Holding current value

$17 Million

Previous $16.6 Million 21.84%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$43.55 - $59.88 $1.75 Million - $2.41 Million	40,280 Added 10.74%	415,500 $20.2 Million
Q2 2024 Oct 17, 2024	BUY	$39.5 - $57.22 $1.31 Million - $1.9 Million	33,187 Added 9.7%	375,220 $16.6 Million
Q2 2024 Aug 14, 2024	BUY	$39.5 - $57.22 $1.31 Million - $1.9 Million	33,187 Added 9.7%	375,220 $16.6 Million
Q1 2024 Oct 17, 2024	SELL	$55.06 - $69.99 $1.83 Million - $2.32 Million	-33,187 Reduced 8.84%	342,033 $19.2 Million
Q1 2024 Aug 16, 2024	SELL	$55.06 - $69.99 $30.2 Million - $38.4 Million	-548,454 Reduced 61.59%	342,033 $19.2 Million
Q1 2024 May 15, 2024	SELL	$55.06 - $69.99 $30.2 Million - $38.4 Million	-548,454 Reduced 61.59%	342,033 $19.2 Million
Q4 2023 Aug 16, 2024	BUY	$57.25 - $69.74 $29.5 Million - $35.9 Million	515,267 Added 137.32%	890,487 $53.6 Million
Q4 2023 Feb 13, 2024	BUY	$57.25 - $69.74 $5.32 Million - $6.47 Million	92,842 Added 11.64%	890,487 $53.6 Million
Q3 2023 Nov 15, 2023	SELL	$63.16 - $76.5 $5.73 Million - $6.94 Million	-90,717 Reduced 10.21%	797,645 $53.6 Million
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $21.3 Million - $34.5 Million	459,610 Added 107.2%	888,362 $61.3 Million
Q1 2023 May 15, 2023	BUY	$43.42 - $57.37 $7.1 Million - $9.38 Million	163,436 Added 61.6%	428,752 $20.7 Million
Q4 2022 Feb 14, 2023	BUY	$38.8 - $55.46 $983,114 - $1.41 Million	25,338 Added 10.56%	265,316 $13.2 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $3.32 Million - $4.97 Million	87,013 Added 56.88%	239,978 $9.79 Million
Q2 2022 Oct 27, 2022	BUY	$33.54 - $55.0 $584,501 - $958,485	17,427 Added 12.86%	152,965 $8.41 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $584,501 - $958,485	17,427 Added 12.86%	152,965 $8.41 Million
Q1 2022 Oct 27, 2022	SELL	$31.02 - $48.18 $540,585 - $839,632	-17,427 Reduced 11.39%	135,538 $4.93 Million
Q1 2022 May 13, 2022	SELL	$31.02 - $48.18 $666,464 - $1.04 Million	-21,485 Reduced 13.68%	135,538 $4.93 Million
Q4 2021 Feb 14, 2022	SELL	$41.14 - $56.98 $1.33 Million - $1.84 Million	-32,268 Reduced 17.05%	157,023 $7.32 Million
Q3 2021 Nov 15, 2021	BUY	$35.31 - $50.56 $6.68 Million - $9.57 Million	189,291 New	189,291 $9.57 Million

Others Institutions Holding LEGN

# of Institutions

225

Shares Held

74.3M

Call Options Held

279K

Put Options Held

350K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.85B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account